Palatin Technologies, Inc.

The recent American College of Cardiology (ACC) conference should have provided companies with the chance to share positive trial updates and saunter into the next trading week with bolstered stock pr

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sionna Gets CF Compounds AbbVie License

The US Food and Drug Administration has given the green light to Cosette Pharmaceuticals to launch the first generic version of originator AbbVie ’s Rectiv (nitroglycerin) ointment, 0.4%. The agenc

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Voyager To Focus First On Hun